Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Record History now lists Revision v3.3.2 and removes Revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:57:16.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The operating-status notice about government funding was removed from the page.
    Difference
    0.7%
    Check dated 2025-11-18T07:11:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The screenshots show the Record History page for NCT02183870 with version entries from 2014 to 2022. The content and structure remain consistent, with only minor UI updates.
    Difference
    0.1%
    Check dated 2025-11-03T21:13:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    12%
    Check dated 2025-10-06T06:52:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:29:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.7%
    Check dated 2025-09-14T21:37:09.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.